Onconetix, Inc. Common Stock (ONCO) Stock Price

ONCOStock

$0.64−99.56%52W

Market Cap$2.54M

P/E—

PEG Ratio—

Div yield—

Beta2.68

ONCO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-109.52%

Price vs S&P 500 (4W)-24.03%

VGM Score32.84

Book Value / Share (Quarterly)$42.64

P/TBV (Annual)0.54x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-35.57

Price vs S&P 500 (YTD)-111.12%

Gross Margin (TTM)79.63%

Net Profit Margin (TTM)-1319.55%

EPS (TTM)$-219.70

10-Day Avg Trading Volume0.27M

EPS Excl Extra (TTM)$-219.70

EPS (Annual)$-748.39

ROI (Annual)-89.00%

Gross Margin (Annual)77.62%

Cash / Share (Quarterly)$13.49

Revenue Growth QoQ (YoY)-78.88%

ROA (Last FY)-56.29%

Revenue Growth TTM (YoY)-61.81%

EBITD / Share (TTM)$-357.45

ROE (5Y Avg)-211.86%

Operating Margin (TTM)-2868.99%

Cash Flow / Share (Annual)$-310.20

P/B Ratio0.30x

P/B Ratio (Quarterly)0.09x

Net Income / Employee (Annual)$-7,016,200

EV / Revenue (TTM)0.02x

Net Interest Coverage (TTM)-3.72x

ROA (TTM)-49.40%

EPS Incl Extra (Annual)$-748.39

Current Ratio (Annual)0.66x

Quick Ratio (Quarterly)1.24x

3-Month Avg Trading Volume0.81M

52-Week Price Return-99.56%

Revenue / Employee (TTM)$367,600

Tangible BV / Share (Quarterly)$69.53

P/S Ratio (Annual)4.27x

Asset Turnover (Annual)0.03x

52-Week High$209.50

EPS Excl Extra (Annual)$-748.39

26-Week Price Return-98.27%

Quick Ratio (Annual)0.61x

13-Week Price Return-46.23%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.41x

Enterprise Value$15,800

Asset Turnover (TTM)0.04x

Revenue / Employee (Annual)$407,700

Pretax Margin (Annual)-1720.91%

Cash / Share (Annual)$167.33

3-Month Return Std Dev126.57%

Net Income / Employee (TTM)$-4,850,700

ROE (Last FY)-89.00%

Net Interest Coverage (Annual)0.10x

EPS Basic Excl Extra (Annual)$-748.39

Receivables Turnover (TTM)24.50x

Total Debt / Equity (Quarterly)0.02x

EPS Incl Extra (TTM)$-219.70

ROI (TTM)-83.66%

P/S Ratio (TTM)4.74x

Revenue / Share (Annual)$43.49

Tangible BV / Share (Annual)$3482.08

Price vs S&P 500 (52W)-117.87%

Year-to-Date Return-99.16%

5-Day Price Return-12.57%

EPS Normalized (Annual)$-748.39

ROA (5Y Avg)-93.87%

Net Profit Margin (Annual)-1720.98%

Month-to-Date Return-20.65%

EBITD / Share (Annual)$-1249.21

Operating Margin (Annual)-2874.50%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-149.88%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-219.70

P/TBV (Quarterly)0.54x

P/B Ratio (Annual)0.15x

Inventory Turnover (TTM)1.02x

Pretax Margin (TTM)-1319.48%

Book Value / Share (Annual)$505.33

Price vs S&P 500 (13W)-49.02%

Beta2.68x

Revenue / Share (TTM)$11.70

ROE (TTM)-104.19%

52-Week Low$0.62

vGradeA

gGradeF

mGradeF

vgmGradeD

ONCO Earnings Surprise History

Q4 22-27200.01est. -45050.02

Q1 23-30600.02est. -34850.02

Q2 23-73100.04est. -30600.02

Q3 23-52700.03est. -32300.02

ONCO Analyst Recommendations

Feb 2024

Mar 2024

Apr 2024

May 2024

2.17

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
ONCOOnconetix, Inc. Common Stock	A	F	F	$0.64
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Onconetix, Inc. Common Stock

Onconetix Inc is a commercial-stage biotechnology company specializing in men's health and oncology solutions. The company markets Entadfi, an FDA-approved once-daily oral therapy for benign prostatic hyperplasia. Beyond its flagship product, Onconetix is developing a pipeline of oncology-focused therapeutics, diagnostics, and clinician services.